Biotech Company

Why Did Vaxxinity (VAXX) Stock Gain 80%?

by InvestorPlace
May 2, 2022April 17, 2023

Friday, Texas-based biotech company Vaxxinity (NASDAQ:VAXX) closed up an unbelievable 84% higher. Specifically, VAXX stock skyrocketed on news that it has completed an important milestone in its… Read More »Why Did Vaxxinity (VAXX) Stock Gain 80%?

An Overlooked Biotech With A Revolutionary Diabetes Drug Creates An Attractive Buying Opportunity

by Bob Mitchell
August 11, 2020April 17, 2021

Since the discovery of insulin almost 100 years ago, there has been no novel therapy introduced for Type 1 diabetes. That could change in the… Read More »An Overlooked Biotech With A Revolutionary Diabetes Drug Creates An Attractive Buying Opportunity